Transcode Therapeutics, Inc. · NASDAQ:RNAZ
Sabby Management, LLC's stake in Transcode Therapeutics, Inc. fell to 4.90% (Schedule 13G/A)
Event Dec 31, 2025 · Filed Jan 7, 2026
Sabby Management, LLC's stake in Transcode Therapeutics, Inc. fell to 4.90%, 41,601 shares, as a passive investor on Dec 31, 2025. Filed Jan 7, 2026 (Schedule 13G/A).
- Stake
- 4.90%
- Shares
- 41,601
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| SABBY MANAGEMENT, LLC | 4.90% | 41,601 |
| SABBY VOLATILITY WARRANT MASTER FUND LTD | 4.90% | 41,601 |
| HAL MINTZ | 4.90% | 41,601 |
Source
Related
- Transcode Therapeutics, Inc.
- Sabby Management, LLC
- Transcode Therapeutics, Inc. shareholders
- Form 4 · CK Life Sciences Intl (Holdings) Inc · Aug 5, 2026
- Schedule 13D/A · CK Life Sciences Intl (Holdings) Inc · Aug 3, 2026
- Schedule 13G · Daniel Eduardo Katzman · Jul 28, 2026
- Schedule 13G · Elena Rosa Braci · Jul 28, 2026
- Schedule 13G · Unleash Immuno Oncolytics, Inc. · Jul 28, 2026